Bixiye
QP49-22 Commercial Pharmacy Benefit Exclusion for Carvykti™, Korsuva™, and Leqvio®
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1911 - 1920 ee natiijooyinka 3167
Bixiye
QP50-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2022
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP39-22 Required Notification of Medicare Organization Determination Request Dismissal and Withdrawal
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP46-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 28, 2022
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP51-22 Blue Cross Preferred Genetic Laboratory Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP53-22 New Operational Trends Dashboard
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
P31R1-22 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2022
Bixiye
P34-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2022